Zujun Que

Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO

Anle Zhang, Yuanhong Zheng, Zujun Que et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 103 citations · Full text

Cancer Immunosurveillance, Immunology, Bronchial Neoplasm +9

Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo

Zujun Que, Bin Luo, Zhiyi Zhou et al. · Cancer Cell International · 2019 · 82 citations · Full text

Altered let-7 expression in Myasthenia gravis and let-7c mediated regulation of IL-10 by directly targeting IL-10 in Jurkat cells

Lin Jiang, Zhuoan Cheng, Shaobo Qiu et al. · International Immunopharmacology · 2012 · 64 citations

Inflammation, Cytokine, Autoimmune Disease +12

Combined chemo-immuno-photothermal therapy based on ursolic acid/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine inhibiting the growth and metastasis of non-small cell lung cancer

Fan Xu, Minghua Li, Zujun Que et al. · Journal of Materials Chemistry B · 2023 · 36 citations · Full text

Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells

Zujun Que, Fangyuan Zou, Anle Zhang et al. · International Immunopharmacology · 2014 · 35 citations

Oncogenic Agent, Apoptosis, Immunology +9